Alivia Anderson

University Writing 1103

Professor Campbell
3/12/16

Annotated Bibliography
"Alzheimer's and Brain Research Center | Alzheimer's Association." Alzheimer's
Association. Alzheimer's Association, n.d. Web. 12 Mar. 2016.

The Alzheimers Association gives information on everything you need to know from basic facts
on Alzheimers symptoms to current research and treatment options. The website also includes
clinical trial information, the official Alzheimers Association Journal, a newsletter, whats new
in the press and you can even type in your personal zip code and find a treatment center near
you. The amount of information is endless and you can find out current and previous information
on this disease. The information is plentiful and you can believe it to be a reliable source because
it is the official Alzheimers Association. However, the website wasnt the easiest to navigate
and the information was all over the place. It was hard to find official authors or who had found
this information. The information was objective and factual with the intention to inform readers.
The audience was for the general population but especially those who want to know more about
Alzheimers and those who think they might have the disease or those with friends or family
with Alzheimers. The overall quality of the source was reliable yet overwhelming. I felt as
though there was too much information and the source was hard to navigate. I will probably use
some of the basic facts and history from this website along with current treatment plans however

I will probably find current articles and new research somewhere else because it will be easier to
determine the credibility of the authors. Overall, this website gave good background on
Alzheimers in general.

Pollack, Andrew. "New Data on 2 Alzheimers Drugs Alters Hope and Expectation." The
New York Times. The New York Times, 22 July 2015. Web. 12 Mar. 2016.

This article was written by Andrew Pollack for the New York Times magazine. Pollack focuses
on the study of two new Alzheimers drugs and their effectiveness and clinical trials. The drugs
were from the companies Lilly and Company and Biogen, both trying to remove or lessen
amyloid plaques located in Alzheimers patients brains. The Lrug from Lilly and Company is
named Solanezumab and they have been doing clinical trials since 2012. Both drugs are proving
to be very helpful but are not very accepted because of them being so new. This is a double blind
study and they hope to have final results for the trials in 2017. This article is reliable due to the
fact that it is published in a scholarly and well known magazine, The New York Times. The
author remained biased with his information stating facts and not giving his opinion on whether
or not he found the drug to be good or bad. The intended audience was mostly for doctors
treating the disease or patients with the disease however, the drug is not out yet. Although the
article was written in 2012, it is still considered new because the drugs are still being tested in
the clinical trials and the full report wont be final until 2017. I found this article to be useful in
regards to my questions on new drugs and research. However, the information on the trials were
somewhat confusing and hard to understand. Therefore, I am not sure if I will be using this
article in my paper because I dont feel like I could fully explain the trials and drugs in a way for

my audience to understand. I might use the names of the drugs in regards to what the new
treatments are.

"New Alzheimer's Treatment Fully Restores Memory Function." ScienceAlert.

ScienceAlert, 18 Mar. 2015. Web. 12 Mar. 2016.

The information found on Science Alert discusses a new, non invasive treatment option for those
suffering from Alzheimers. The study is being conducted by Queensland Brain Institute at the
University of Queensland in Australia. The research was also published in Science Transitional
Medicine. The method of using an ultrasound to send waves into the brain was tested on Mice
and reportedly 75% of the Mice were cured. They have called this approach a real breakthrough
due to its effectiveness and lack of side effects. Human trials are said to begin in 2017. This is a
reliable, non biased source with factual and credible information. Science Alert provides real
facts and information and is a reliable source. It is also published in other sources and there is a
direct quote from one of the researchers himself along with a recording of the interview. The
intended audience is all of those keeping up with new methods of treatment and those who need
treatment for the disease themselves. I will definitely be using this source. The method and its
effectiveness is inspiring and really interested me further with my Alzheimers research. The
information was easy to understand and broken down for those with little knowledge of the topic.
This is the type of innovative research I was hoping to include in my paper to show my audience
that there is hope and hopefully a cure for this devastating disease. Based on this article, I also
plan on researching the Queensland Brain Institute further.

"5 Alzheimer's Disease Myths: Risk Factors, Memory Loss, Prevention, and More."
WebMD. WebMD, n.d. Web. 13 Mar. 2016.

WebMD provided lots of information on the basics of the Alzheimers disease which included
common misconceptions, the stages of the disease and treatment options. The myths were stated
with research backing the reason why the concept was wrong. There was also a clear list of the
seven stages of Alzheimers. There was no clear author to give credit to however WebMD is a
reliable source of its own. The information was pure facts with no biased information or
opinions. The information however was basic and not as up to date with new, groundbreaking
research or treatment options. The overall quality of the source was very good and gave a good
background on the disease. The information was easy to understand and therefore probably
intended for those who dont know much about the disease. I will probably be using some parts
of this source. The myths were interesting and some of them I thought were true before learning
about on WebMD and therefore I will probably include them in my paper. When it comes to the
new or current news on Alzheimers, it proved to be unsatisfactory with its information. This
was a source intended to give more of a basic knowledge on the disease.